Alzheimer’s scientist indicted for allegedly falsifying data in $16M scheme
Enlarge (credit: Getty | Pavlo Gonchar)
A federal grand jury has indicted an embattled Alzheimer's researcher for allegedly falsifying data to fraudulently obtain $16 million in federal research funding from the National Institutes of Health for the development of a controversial Alzheimer's drug and diagnostic test.
Hoau-Yan Wang, 67, a medical professor at the City University of New York, was a paid collaborator with the Austin, Texas-based pharmaceutical company Cassava Sciences.
Заголовки